Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 2139 results found since Jan 2013.

Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic
Expert Rev Anticancer Ther. 2022 Jun 9. doi: 10.1080/14737140.2022.2088514. Online ahead of print.ABSTRACTINTRODUCTION: Oropharyngeal cancer (OPC) will be among the most common cancers in men by 2045 due to a rapid rise in human papillomavirus (HPV)-related OPC. Those who survive their cancer often suffer life-long treatment effects and early death. HPV vaccination could prevent virtually all HPV-related cancers but is not an effective preventive strategy for those already exposed. Without a dramatic increase in vaccine uptake, especially in the young, In the U.S., HPV vaccination will have a negligible effect on OPC incid...
Source: Expert Review of Anticancer Therapy - June 9, 2022 Category: Cancer & Oncology Authors: Ari Schuman Karen S Anderson Andrew T Day Jay Ferrell Erich M Sturgis Kristina R Dahlstrom Source Type: research

IJERPH, Vol. 19, Pages 10207: HPV Vaccination Intentions of Female Students in Chinese Universities: A Systematic Literature Review and Meta-Analysis
Conclusion: The intention rate of HPV vaccination among female university students in China is low and varies among different populations. There is a need to increase HPV vaccination promotion efforts to improve the intention of female university students to receive the vaccine.
Source: International Journal of Environmental Research and Public Health - August 17, 2022 Category: Environmental Health Authors: Yiming Bai Patrick Ip Karen Chan Hextan Ngan Paul Yip Tags: Review Source Type: research

Emerging Intralesional Treatments for Plantar Warts: A Systematic Review
CONCLUSION: Intralesional vitamin D3, in particular, demonstrated promising results as a potential second- or even first-line agent although not accessible in the United States. Candida antigen and bleomycin are less effective than intralesional vitamin D3, but given their greater accessibility and superiority to cryotherapy, should continue to be considered for treating recalcitrant plantar warts. Moreover, the quadrivalent human papillomavirus (HPV) vaccine, showing success in case reports, warrants further attention for both the treatment and prevention of plantar warts. J Drugs Dermatol. 2022;21(12):1322-1329. doi:10.3...
Source: Journal of Drugs in Dermatology - December 5, 2022 Category: Dermatology Authors: Amylee Martin Akshitha Thatiparthi Niki Nourmohammadi Cristina Nguyen Calvin Sung Natasha Atanaskova Mesinkovska Source Type: research

Health inequities in human papillomavirus prevention, diagnostics and clinical care in the USA: a scoping review
Conclusion Findings from our review demonstrate clear gaps in HPV-related inequity research. Vaccine completion, provider recommendation and intersectionality should continue to be evaluated to implement targeted interventions.
Source: Sexually Transmitted Infections - February 17, 2023 Category: Sexual Medicine Authors: Magana, K., Strand, L., Love, M., Moore, T., Pena, A., Ito Ford, A., Vassar, M. Tags: Review Source Type: research

Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis
Conclusion HPV vaccine communication is critical in ensuring that the community understands the importance of vaccination. The most effective communication strategies included those which educate the population about the HPV vaccine, facilitate decision-making on vaccine uptake and community ownership of the vaccination process immunisation. PROSPERO registration number CRD42021243683.
Source: BMJ Open - April 3, 2023 Category: General Medicine Authors: Oketch, S. Y., Ochomo, E. O., Orwa, J. A., Mayieka, L. M., Abdullahi, L. H. Tags: Open access, Communication Source Type: research